226 related articles for article (PubMed ID: 19783829)
1. Combining tissue transcriptomics and urine metabolomics for breast cancer biomarker identification.
Nam H; Chung BC; Kim Y; Lee K; Lee D
Bioinformatics; 2009 Dec; 25(23):3151-7. PubMed ID: 19783829
[TBL] [Abstract][Full Text] [Related]
2. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.
Ou K; Yu K; Kesuma D; Hooi M; Huang N; Chen W; Lee SY; Goh XP; Tan LK; Liu J; Soon SY; Bin Abdul Rashid S; Putti TC; Jikuya H; Ichikawa T; Nishimura O; Salto-Tellez M; Tan P
J Proteome Res; 2008 Apr; 7(4):1518-28. PubMed ID: 18318472
[TBL] [Abstract][Full Text] [Related]
3. RRLC-MS/MS-based metabonomics combined with in-depth analysis of metabolic correlation network: finding potential biomarkers for breast cancer.
Chen Y; Zhang R; Song Y; He J; Sun J; Bai J; An Z; Dong L; Zhan Q; Abliz Z
Analyst; 2009 Oct; 134(10):2003-11. PubMed ID: 19768207
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.
Rody A; Karn T; Gätje R; Kourtis K; Minckwitz G; Loibl S; Munnes M; Ruckhäberle E; Holtrich U; Kaufmann M; Ahr A
Zentralbl Gynakol; 2006 Apr; 128(2):76-81. PubMed ID: 16673249
[TBL] [Abstract][Full Text] [Related]
5. Metabolomic study for diagnostic model of oesophageal cancer using gas chromatography/mass spectrometry.
Wu H; Xue R; Lu C; Deng C; Liu T; Zeng H; Wang Q; Shen X
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3111-7. PubMed ID: 19716777
[TBL] [Abstract][Full Text] [Related]
6. Gene expression signatures and biomarkers of noninvasive and invasive breast cancer cells: comprehensive profiles by representational difference analysis, microarrays and proteomics.
Nagaraja GM; Othman M; Fox BP; Alsaber R; Pellegrino CM; Zeng Y; Khanna R; Tamburini P; Swaroop A; Kandpal RP
Oncogene; 2006 Apr; 25(16):2328-38. PubMed ID: 16314837
[TBL] [Abstract][Full Text] [Related]
7. Clinical proteomics in breast cancer: a review.
Gast MC; Schellens JH; Beijnen JH
Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
[TBL] [Abstract][Full Text] [Related]
8. Robust and efficient identification of biomarkers by classifying features on graphs.
Hwang T; Sicotte H; Tian Z; Wu B; Kocher JP; Wigle DA; Kumar V; Kuang R
Bioinformatics; 2008 Sep; 24(18):2023-9. PubMed ID: 18653521
[TBL] [Abstract][Full Text] [Related]
9. Identification of Cystatin SN as a novel tumor marker for colorectal cancer.
Yoneda K; Iida H; Endo H; Hosono K; Akiyama T; Takahashi H; Inamori M; Abe Y; Yoneda M; Fujita K; Kato S; Nozaki Y; Ichikawa Y; Uozaki H; Fukayama M; Shimamura T; Kodama T; Aburatani H; Miyazawa C; Ishii K; Hosomi N; Sagara M; Takahashi M; Ike H; Saito H; Kusakabe A; Nakajima A
Int J Oncol; 2009 Jul; 35(1):33-40. PubMed ID: 19513549
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers in breast cancer.
Vivanco Md
Methods Mol Biol; 2010; 593():137-56. PubMed ID: 19957148
[TBL] [Abstract][Full Text] [Related]
11. Challenges in projecting clustering results across gene expression-profiling datasets.
Lusa L; McShane LM; Reid JF; De Cecco L; Ambrogi F; Biganzoli E; Gariboldi M; Pierotti MA
J Natl Cancer Inst; 2007 Nov; 99(22):1715-23. PubMed ID: 18000217
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of colorectal cancer gene expression profiling studies identifies consistently reported candidate biomarkers.
Chan SK; Griffith OL; Tai IT; Jones SJ
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):543-52. PubMed ID: 18349271
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation biomarkers of prostate cancer: confirmation of candidates and evidence urine is the most sensitive body fluid for non-invasive detection.
Payne SR; Serth J; Schostak M; Kamradt J; Strauss A; Thelen P; Model F; Day JK; Liebenberg V; Morotti A; Yamamura S; Lograsso J; Sledziewski A; Semjonow A
Prostate; 2009 Sep; 69(12):1257-69. PubMed ID: 19459176
[TBL] [Abstract][Full Text] [Related]
14. Integration of metabolomics and transcriptomics data to aid biomarker discovery in type 2 diabetes.
Connor SC; Hansen MK; Corner A; Smith RF; Ryan TE
Mol Biosyst; 2010 May; 6(5):909-21. PubMed ID: 20567778
[TBL] [Abstract][Full Text] [Related]
15. Cancer biomarker discovery: Opportunities and pitfalls in analytical methods.
Issaq HJ; Waybright TJ; Veenstra TD
Electrophoresis; 2011 Apr; 32(9):967-75. PubMed ID: 21449066
[TBL] [Abstract][Full Text] [Related]
16. Combining serial analysis of gene expression and array technologies to identify genes differentially expressed in breast cancer.
Nacht M; Ferguson AT; Zhang W; Petroziello JM; Cook BP; Gao YH; Maguire S; Riley D; Coppola G; Landes GM; Madden SL; Sukumar S
Cancer Res; 1999 Nov; 59(21):5464-70. PubMed ID: 10554019
[TBL] [Abstract][Full Text] [Related]
17. Identification of aberrant chromosomal regions from gene expression microarray studies applied to human breast cancer.
Buness A; Kuner R; Ruschhaupt M; Poustka A; Sültmann H; Tresch A
Bioinformatics; 2007 Sep; 23(17):2273-80. PubMed ID: 17599933
[TBL] [Abstract][Full Text] [Related]
18. Mass spectrometry based metabolomic approaches in urinary biomarker study of women's cancers.
Woo HM; Kim KM; Choi MH; Jung BH; Lee J; Kong G; Nam SJ; Kim S; Bai SW; Chung BC
Clin Chim Acta; 2009 Feb; 400(1-2):63-9. PubMed ID: 19010317
[TBL] [Abstract][Full Text] [Related]
19. Estrogen and progesterone receptor isoforms: clinical significance in breast cancer.
Fuqua SA; Cui Y
Breast Cancer Res Treat; 2004; 87 Suppl 1():S3-10. PubMed ID: 15597215
[TBL] [Abstract][Full Text] [Related]
20. Population-based molecular prognosis of breast cancer by transcriptional profiling.
Ma Y; Qian Y; Wei L; Abraham J; Shi X; Castranova V; Harner EJ; Flynn DC; Guo L
Clin Cancer Res; 2007 Apr; 13(7):2014-22. PubMed ID: 17404081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
